Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Long-Term Debt Repayments (2016 - 2024)

Conmed (CNMD) has disclosed Long-Term Debt Repayments for 10 consecutive years, with $70.0 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Long-Term Debt Repayments changed N/A year-over-year to $70.0 million, compared with a TTM value of $70.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $70.0 million, changed N/A over the prior year.
  • Long-Term Debt Repayments was $70.0 million for Q1 2024 at Conmed, up from -$3.3 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $70.0 million in Q1 2024 and bottomed at -$9.9 million in Q4 2020.
  • Average Long-Term Debt Repayments over 3 years is $10.0 million, with a median of $3.3 million recorded in 2020.
  • Peak annual rise in Long-Term Debt Repayments hit 0.03% in 2020, while the deepest fall reached 400.06% in 2020.
  • Year by year, Long-Term Debt Repayments stood at -$9.9 million in 2020, then soared by 66.66% to -$3.3 million in 2021, then skyrocketed by 2212.89% to $70.0 million in 2024.
  • Business Quant data shows Long-Term Debt Repayments for CNMD at $70.0 million in Q1 2024, -$3.3 million in Q2 2021, and $3.3 million in Q1 2021.